Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01510288 | Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer | terminated | Phase 1 | 28 | Amsterdam UMC, location VUmcOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT00401401 | Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 30 | GenmabINDUSTRY | 5 | Dec 23, 2011 | clinicaltrials |
| NCT00432419 |
| Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy. |
| terminated |
| Phase 1 / Phase 2 |
| 1 |
| French National Agency for Research on AIDS and Viral HepatitisOTHER_GOV |
| 1 |
| Dec 22, 2011 |
| clinicaltrials |
| NCT01106235 | Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma | terminated | Phase 1 | 12 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 21, 2011 | clinicaltrials |
| NCT00473551 | Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 19, 2011 | clinicaltrials |
| NCT00533169 | ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma | terminated | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 15, 2011 | clinicaltrials |
| NCT01313390 | Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer(DORA) | terminated | Phase 1 / Phase 2 | 4 | University College, LondonOTHER | 1 | Dec 12, 2011 | clinicaltrials |
| NCT00410865 | Wild Type p53 Adenovirus for Oral Premalignancies | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00593008 | Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer | terminated | Phase 1 | 5 | Massachusetts General HospitalOTHER | 1 | Dec 2, 2011 | clinicaltrials |
| NCT00400764 | A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas | terminated | Phase 1 / Phase 2 | 72 | Genentech, Inc.INDUSTRY | 0 | Nov 23, 2011 | clinicaltrials |
| NCT00587015 | A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL) | terminated | Phase 1 | 50 | MedImmune LLCINDUSTRY | 2 | Nov 22, 2011 | clinicaltrials |
| NCT01242943 | Radioimmunotherapy With 131I-L19SIP in Patients With Cancer | terminated | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 2 | Nov 22, 2011 | clinicaltrials |
| NCT00796055 | Study of MEDI-547 to Evaluate the Safety, Tolerability, and Biologic Activity of IV Administration in Subjects With Relapsed or Refractory Solid Tumors(MEDI-547) | terminated | Phase 1 | 6 | MedImmune LLCINDUSTRY | 1 | Nov 17, 2011 | clinicaltrials |
| NCT00779311 | A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer | terminated | Phase 1 | 8 | Accelerated Community Oncology Research NetworkOTHER | 1 | Nov 2, 2011 | clinicaltrials |
| NCT00747825 | Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma | terminated | Phase 1 | 12 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00430443 | Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML | terminated | Phase 1 | 3 | Callisto PharmaceuticalsINDUSTRY | 1 | Aug 31, 2011 | clinicaltrials |
| NCT00281996 | Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer | terminated | Phase 1 | 19 | Northwestern UniversityOTHER | 1 | Aug 26, 2011 | clinicaltrials |
| NCT00023790 | Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin | terminated | Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00732745 | Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction | terminated | Phase 1 | 9 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 22, 2011 | clinicaltrials |
| NCT00839059 | Lenalidomide In Patients With Acute Myeloid Leukemia | terminated | Phase 1 | 14 | University of UlmOTHER | 1 | Jul 29, 2011 | clinicaltrials |
| NCT00683085 | Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 2 | Tokyo UniversityOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00880867 | Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma | terminated | Phase 1 | 3 | Nevada Cancer InstituteOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT00886457 | 5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates | terminated | Phase 1 | 3 | Nevada Cancer InstituteOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT00768339 | A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas | terminated | Phase 1 / Phase 2 | 25 | Aegera TherapeuticsINDUSTRY | 2 | Jul 13, 2011 | clinicaltrials |
| NCT00658801 | Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma | terminated | Phase 1 | 4 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00369447 | A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 52 | YM BioSciencesINDUSTRY | 3 | Jul 1, 2011 | clinicaltrials |
| NCT00112619 | Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors | terminated | Phase 1 | 19 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00415454 | Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma | terminated | Phase 1 | 8 | Henry Ford Health SystemOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00539331 | Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients | terminated | Phase 1 | 6 | AstraZenecaINDUSTRY | 1 | Jun 1, 2011 | clinicaltrials |
| NCT00494611 | A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients | terminated | Phase 1 | 25 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | May 19, 2011 | clinicaltrials |
| NCT00522574 | A Safety Study of XL019 in Adults With Myelofibrosis | terminated | Phase 1 | 100 | ExelixisINDUSTRY | 1 | Apr 5, 2011 | clinicaltrials |
| NCT00496223 | A Phase I/II Study of Sunitinib and Dacarbazine | terminated | Phase 1 / Phase 2 | 11 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT00473616 | Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan | terminated | Phase 1 | 60 | AstraZenecaINDUSTRY | 1 | Feb 11, 2011 | clinicaltrials |
| NCT00937664 | Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine | terminated | Phase 1 | 24 | AstraZenecaINDUSTRY | 1 | Feb 7, 2011 | clinicaltrials |
| NCT00050687 | Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies | terminated | Phase 1 / Phase 2 | — | Titan PharmaceuticalsINDUSTRY | 1 | Jan 28, 2011 | clinicaltrials |
| NCT00460460 | Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies | terminated | Phase 1 | 75 | AstraZenecaINDUSTRY | 2 | Jan 25, 2011 | clinicaltrials |
| NCT00354562 | A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 75 | AbbottINDUSTRY | 4 | Jan 7, 2011 | clinicaltrials |
| NCT00651443 | Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma | terminated | Phase 1 | 20 | BiogenINDUSTRY | 1 | Jan 7, 2011 | clinicaltrials |
| NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | terminated | Phase 1 | 10 | Novartis PharmaceuticalsINDUSTRY | 1 | Jan 6, 2011 | clinicaltrials |
| NCT01270906 | Safety of CHIR-258 (TKI258) in Advanced Solid Tumors | terminated | Phase 1 | 35 | Novartis PharmaceuticalsINDUSTRY | 1 | Jan 5, 2011 | clinicaltrials |
| NCT00486265 | Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML) | terminated | Phase 1 | 47 | AstraZenecaINDUSTRY | 2 | Dec 21, 2010 | clinicaltrials |
| NCT00733031 | Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918 | terminated | Phase 1 | 75 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT01116154 | Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma | terminated | Phase 1 | 30 | City of Hope Medical CenterOTHER | 1 | Dec 9, 2010 | clinicaltrials |
| NCT00102024 | Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma | terminated | Phase 1 / Phase 2 | 30 | BiogenINDUSTRY | 1 | Aug 27, 2010 | clinicaltrials |
| NCT00791544 | Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma | terminated | Phase 1 / Phase 2 | 13 | SanofiINDUSTRY | 1 | Aug 4, 2010 | clinicaltrials |
| NCT00177853 | Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer | terminated | Phase 1 | 23 | University of PittsburghOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00279773 | Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid Leukemia | terminated | Phase 1 | 34 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 30, 2010 | clinicaltrials |
| NCT00003567 | Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | terminated | Phase 1 | 8 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00077103 | Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer | terminated | Phase 1 / Phase 2 | 4 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00646165 | Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia | terminated | Phase 1 | 1 | Mundipharma Research LimitedINDUSTRY | 1 | Mar 31, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Jan 16, 2012source: clinicaltrials